KRAS and cancer: This metabolic reprogramming, which is critical for Apc-Kras mutant cells is considered a hallmark of cancer and high-Grp78 levels are required for this switch, because Grp78 heterozygosity reverts this phenotype (Hanahan & Weinberg, 2011).